Iberaplus Tablet 150/12.5 mg

Adult dose

The medication is administered once daily regardless of meals. 1. For patients whose blood pressure is not sufficiently controlled with monotherapy: - Administer 1 tablet of Irbesartan 150 mg/Hydrochlorothiazide 12.5 mg once daily - Administer 1 tablet of Irbesartan 300 mg/Hydrochlorothiazide 12.5 mg once daily - Administer 1 tablet of Irbesartan 300 mg/Hydrochlorothiazide 25 mg once daily

Child dose

The safety and efficacy of this medication have not been established in children and adolescents under the age of 18.

This drug can cause severe harm to the fetus and newborn, especially during the second and third trimesters, so pregnant women or women who may become pregnant should not take it. If pregnancy is confirmed, use should be discontinued immediately, and it is also safe for breastfeeding women to avoid using this medication. This medication should not be administered to patients with severely impaired kidney function, anuria, or certain liver diseases. Additionally, individuals with allergies to any of the components or a history of hypersensitivity should not take this medication. Patients with hypotension or problems with renal blood vessels, decreased liver function, or heart valve disease should use this medication cautiously. Due to the hydrochlorothiazide component, there may be an increased risk of skin cancer, so it is important to limit sun exposure and regularly check skin conditions. While taking this medication, side effects such as dizziness, fatigue, nausea, abnormal urination may occur, so caution is advised, and if symptoms persist, it is necessary to consult a doctor. Regular blood tests to monitor kidney function and electrolyte levels are necessary, especially to ensure potassium levels do not become too high or too low. If taken with other blood pressure medications, diuretics, lithium, or diabetes medications, drug interactions can occur, so it is essential to discuss this with healthcare professionals. Caution is necessary when driving or operating machinery due to potential dizziness or fatigue, and in cases of hypotension, adequate salt intake and hydration should be maintained. This medication is not recommended for children or adolescents, as safety and effectiveness have not been established. Elderly individuals may be more sensitive to this medication, so special care is needed when taking it. In the case of overdose, symptoms of hypotension, electrolyte imbalance, and dehydration may occur, requiring immediate medical attention. The medication should be stored out of reach of children and kept sealed in its original container.

Serious side effects

Hives, severe swelling (edema), angioedema, chest tightness, difficulty breathing, anaphylactic shock, jaundice, hepatitis, severe skin reactions such as toxic epidermal necrolysis (Lyell syndrome), necrotizing vasculitis, vasculitis, acute vasculitis, intestinal vascular edema, severe allergic reactions, severe swelling, acute angle-closure glaucoma, severe neurological symptoms (headache, thunderclap headache, seizures, confusion, visual disturbances, paralysis), decreased urine output

Mild side effects

• Dizziness
• fatigue
• nausea/vomiting
• abnormal urination
• increased BUN
• elevated creatine kinase
• increased creatinine
• headache
• fainting
• hypotension

This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to store it at room temperature between 1 degree and 30 degrees Celsius.

Appearance

Pink, double-convex, oval-shaped film-coated tablets

Package unit

30 tablets/box [(10 tablets/PTP x 3)], 30 tablets/bottle, 100 tablets/bottle